HNF4A genetic variants: role in diabetes

Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):397-402. doi: 10.1097/MCO.0b013e3281e3888d.

Abstract

Purpose of review: Variants in the hepatocyte nuclear factor 4alpha (HNF4A) gene play a role in the development of diabetes mellitus. Although genetic variation in and around HNF4A regulatory regions has received considerable attention, the significance of these variants in the common type 2 diabetes varies in the literature. This review will provide a general overview of recent genetic studies involving the evaluation of HNF4A as a contributor to the risk and pathophysiology of diabetes mellitus and related risk factors.

Recent findings: These studies report newly identified variants, evaluate previously reported polymorphisms that were associated with type 2 diabetes in several distinct populations with maturity-onset diabetes of the young, type 2 diabetes, gestational diabetes, and diabetes related risk factors, and propose a role for HNF4A in insulin secretion via the potassium ATP channel.

Summary: HNF4A variants identified so far appear to modestly contribute to predisposition for type 2 diabetes. Continued identification and especially functional characterization of variants, however, will be critical in future studies to enhance our understanding of the metabolic impact of this gene.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Age of Onset
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes, Gestational / genetics*
  • Diabetes, Gestational / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation*
  • Hepatocyte Nuclear Factor 4 / genetics*
  • Hepatocyte Nuclear Factor 4 / metabolism
  • Humans
  • Polymorphism, Single Nucleotide*
  • Pregnancy
  • Risk Factors

Substances

  • HNF4A protein, human
  • Hepatocyte Nuclear Factor 4